1nhx: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
[[Image:1nhx.jpg|left|200px]]
[[Image:1nhx.jpg|left|200px]]


{{Structure
<!--
|PDB= 1nhx |SIZE=350|CAPTION= <scene name='initialview01'>1nhx</scene>, resolution 2.10&Aring;
The line below this paragraph, containing "STRUCTURE_1nhx", creates the "Structure Box" on the page.
|SITE=
You may change the PDB parameter (which sets the PDB file loaded into the applet)  
|LIGAND= <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=FTB:N-{4-[1-(2-FLUOROBENZYL)-3-BUTYL-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YLMETHYL]-PHENYL}-ACETAMIDE'>FTB</scene>, <scene name='pdbligand=MN:MANGANESE+(II)+ION'>MN</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene>, <scene name='pdbligand=PEP:PHOSPHOENOLPYRUVATE'>PEP</scene>
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
|ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Phosphoenolpyruvate_carboxykinase_(GTP) Phosphoenolpyruvate carboxykinase (GTP)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=4.1.1.32 4.1.1.32] </span>
or leave the SCENE parameter empty for the default display.
|GENE= PCK1 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])
-->
|DOMAIN=
{{STRUCTURE_1nhx| PDB=1nhx  | SCENE= }}  
|RELATEDENTRY=[[1khb|1KHB]], [[1m51|1M51]]
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1nhx FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1nhx OCA], [http://www.ebi.ac.uk/pdbsum/1nhx PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1nhx RCSB]</span>
}}


'''PEPCK COMPLEX WITH A GTP-COMPETITIVE INHIBITOR'''
'''PEPCK COMPLEX WITH A GTP-COMPETITIVE INHIBITOR'''
Line 27: Line 24:
X-ray structures of two xanthine inhibitors bound to PEPCK and N-3 modifications of substituted 1,8-dibenzylxanthines., Foley LH, Wang P, Dunten P, Ramsey G, Gubler ML, Wertheimer SJ, Bioorg Med Chem Lett. 2003 Nov 3;13(21):3871-4. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/14552798 14552798]
X-ray structures of two xanthine inhibitors bound to PEPCK and N-3 modifications of substituted 1,8-dibenzylxanthines., Foley LH, Wang P, Dunten P, Ramsey G, Gubler ML, Wertheimer SJ, Bioorg Med Chem Lett. 2003 Nov 3;13(21):3871-4. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/14552798 14552798]
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Phosphoenolpyruvate carboxykinase (GTP)]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Dunten, P.]]
[[Category: Dunten, P.]]
Line 35: Line 31:
[[Category: Wang, P.]]
[[Category: Wang, P.]]
[[Category: Wertheimer, S J.]]
[[Category: Wertheimer, S J.]]
[[Category: gluconeogenesis]]
[[Category: Gluconeogenesis]]
[[Category: inhibitor]]
[[Category: Inhibitor]]
[[Category: xanthine]]
[[Category: Xanthine]]
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 02:32:56 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 22:30:40 2008''

Revision as of 02:32, 3 May 2008

File:1nhx.jpg

Template:STRUCTURE 1nhx

PEPCK COMPLEX WITH A GTP-COMPETITIVE INHIBITOR


OverviewOverview

The analysis of the X-ray structures of two xanthine inhibitors bound to PEPCK and a comparison to the X-ray structure of GTP bound to PEPCK are reported. The SAR at N-1, N-7 and developing SAR at C-8 are consistent with information gained from the X-ray structures of compounds 1 and 2 bound to PEPCK. Representative N-3 modifications of compound 2 that led to the discovery of 3-cyclopropylmethyl and its carboxy analogue as optimal N-3 groups are presented.

DiseaseDisease

Known disease associated with this structure: Hypoglycemia due to PCK1 deficiency (1) OMIM:[261680]

About this StructureAbout this Structure

1NHX is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

ReferenceReference

X-ray structures of two xanthine inhibitors bound to PEPCK and N-3 modifications of substituted 1,8-dibenzylxanthines., Foley LH, Wang P, Dunten P, Ramsey G, Gubler ML, Wertheimer SJ, Bioorg Med Chem Lett. 2003 Nov 3;13(21):3871-4. PMID:14552798 Page seeded by OCA on Sat May 3 02:32:56 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA